Regulatory Updates

The UK Medicines and Healthcare products Regulatory Agency (MHRA) released a list of Field Safety Notices issued between 27 April and 1 May 2026.

The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices covering the period 11‑15 May 2026.

The MHRA reports rare cases where the Allurion Gastric Balloon failed to transit, causing gastric outlet obstruction, small bowel obstruction, or gastric perforation.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued a list of field safety notices covering the period 25 to 29 May 2026.

Teva UK Limited has identified a labeling mistake on the Ponlimsi (Denosumab) 60 mg pre‑filled syringe carton, which incorrectly states “For application to the skin” despite the product being licensed for subcutaneous injection.

The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices covering 18‑22 May 2026.

Cadila Pharmaceuticals notified the MHRA of an incorrect EAN barcode on cartons of a batch of Mirtazapine 30mg film-coated tablets distributed by Crescent Pharma.

The UK Medicines and Healthcare products Regulatory Agency released a list of Field Safety Notices covering the period 15 to 19 June 2026.

Brancaster Pharma informed the MHRA that cartons for the listed batches were supplied with an outdated Patient Information Leaflet.

Flamingo Pharma UK Ltd notified the MHRA that some packs of Flucloxacillin Capsules BP 500 mg were supplied with the Patient Information Leaflet for Amoxicillin 500 mg, prompting a recall.

The UK Medicines and Healthcare products Regulatory Agency released a list of field safety notices covering drugs and devices from 29 June to 3 July 2026.

The UK Medicines and Healthcare products Regulatory Agency released its July 2026 safety roundup, highlighting recent advice for medicines and medical device users.